<PubmedArticle><MedlineCitation Status="Publisher" Owner="NLM"><PMID Version="1">39496810</PMID><DateRevised><Year>2024</Year><Month>11</Month><Day>04</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1759-5037</ISSN><JournalIssue CitedMedium="Internet"><PubDate><Year>2024</Year><Month>Nov</Month><Day>04</Day></PubDate></JournalIssue><Title>Nature reviews. Endocrinology</Title><ISOAbbreviation>Nat Rev Endocrinol</ISOAbbreviation></Journal><ArticleTitle>Looking back at the TEDDY study: lessons and future directions.</ArticleTitle><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41574-024-01045-0</ELocationID><Abstract><AbstractText>The goal of the TEDDY (The Environmental Determinants of Diabetes in the Young) study is to elucidate factors leading to the initiation of islet autoimmunity (first primary outcome) and those related to progression to type 1 diabetes mellitus (T1DM; second primary outcome). This Review outlines the key findings so far, particularly related to the first primary outcome. The background, history and organization of the study are discussed. Recruitment and follow-up (from age 4 months to 15 years) of 8,667 children showed high retention and compliance. End points of the presence of autoantibodies against insulin, GAD65, IA-2 and ZnT8 revealed the HLA-associated early appearance of insulin autoantibodies (1-3 years of age) and the later appearance of GAD65 autoantibodies. Competing autoantibodies against tissue transglutaminase (marking coeliac disease autoimmunity) also appeared early (2-4 years). Genetic and environmental factors, including enterovirus infection and gastroenteritis, support mechanistic differences underlying one phenotype of autoimmunity against insulin and another against GAD65. Infant growth and both probiotics and high protein intake affect the two phenotypes differently, as do serious life events during pregnancy. As the end of the TEDDY sampling phase is approaching, major omics approaches are in progress to further dissect the mechanisms that might explain the two possible endotypes of T1DM.</AbstractText><CopyrightInformation>© 2024. Springer Nature Limited.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lernmark</LastName><ForeName>Åke</ForeName><Initials>Å</Initials><Identifier Source="ORCID">0000-0003-1735-0499</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden. ake.lernmark@med.lu.se.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Agardh</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akolkar</LastName><ForeName>Beena</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gesualdo</LastName><ForeName>Patricia</ForeName><Initials>P</Initials><Identifier Source="ORCID">0009-0006-0689-4262</Identifier><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hagopian</LastName><ForeName>William A</ForeName><Initials>WA</Initials><AffiliationInfo><Affiliation>Department of Pediatrics, Indiana University School of Medicine, Indianapolis, IN, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Haller</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0002-2803-1824</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hyöty</LastName><ForeName>Heikki</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Virology, Faculty of Medicine and Health Technology, Tampere University, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Johnson</LastName><ForeName>Suzanne Bennett</ForeName><Initials>SB</Initials><Identifier Source="ORCID">0000-0001-5721-7524</Identifier><AffiliationInfo><Affiliation>Department of Behavioral Sciences and Social Medicine, Florida State University College of Medicine, Tallahassee, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Larsson</LastName><ForeName>Helena Elding</ForeName><Initials>HE</Initials><Identifier Source="ORCID">0000-0003-3306-1742</Identifier><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Edwin</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Digestive Health Institute, Department of Pediatrics, School of Medicine, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lynch</LastName><ForeName>Kristian F</ForeName><Initials>KF</Initials><AffiliationInfo><Affiliation>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McKinney</LastName><ForeName>Eoin F</ForeName><Initials>EF</Initials><AffiliationInfo><Affiliation>Department of Medicine, University of Cambridge School of Clinical Medicine, Cambridge, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>McIndoe</LastName><ForeName>Richard</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Center for Biotechnology and Genomic Medicine, Medical College of Georgia, Augusta University, Augusta, GA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Melin</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Clinical Sciences, Lund University CRC, Skåne University Hospital, Malmö, Sweden.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Norris</LastName><ForeName>Jill M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Epidemiology, Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rewers</LastName><ForeName>Marian</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Barbara Davis Center for Diabetes, University of Colorado, Aurora, CO, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rich</LastName><ForeName>Stephen S</ForeName><Initials>SS</Initials><Identifier Source="ORCID">0000-0003-3872-7793</Identifier><AffiliationInfo><Affiliation>Center for Public Health Genomics, University of Virginia, Charlottesville, VA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Toppari</LastName><ForeName>Jorma</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Paediatrics, Turku University Hospital, Turku, Finland.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Biomedicine, Research Centre for Integrated Physiology and Pharmacology, University of Turku, Turku, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triplett</LastName><ForeName>Eric</ForeName><Initials>E</Initials><Identifier Source="ORCID">0000-0002-1845-4866</Identifier><AffiliationInfo><Affiliation>University of Florida, Department of Microbiology and Cell Science, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vehik</LastName><ForeName>Kendra</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Virtanen</LastName><ForeName>Suvi M</ForeName><Initials>SM</Initials><AffiliationInfo><Affiliation>Center for Child Health Research, Tampere University and University Hospital and Research, Tampere, Finland.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ziegler</LastName><ForeName>Anette-G</ForeName><Initials>AG</Initials><AffiliationInfo><Affiliation>Institute of Diabetes Research, Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Forschergruppe Diabetes e.V. at Helmholtz Zentrum München, Deutsches Forschungszentrum für Gesundheit und Umwelt, Munich, Germany.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Forschergruppe Diabetes, Klinikum rechts der Isar, Technische Universität München and e.V., Munich, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schatz</LastName><ForeName>Desmond A</ForeName><Initials>DA</Initials><Identifier Source="ORCID">0000-0003-3267-8265</Identifier><AffiliationInfo><Affiliation>Department of Pediatrics, University of Florida, Gainesville, FL, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Krischer</LastName><ForeName>Jeffrey</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Health Informatics Institute, Morsani College of Medicine, University of South Florida, Tampa, FL, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>11</Month><Day>04</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Rev Endocrinol</MedlineTA><NlmUniqueID>101500078</NlmUniqueID><ISSNLinking>1759-5029</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>11</Month><Day>5</Day><Hour>0</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>11</Month><Day>4</Day><Hour>23</Hour><Minute>32</Minute></PubMedPubDate></History><PublicationStatus>aheadofprint</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39496810</ArticleId><ArticleId IdType="doi">10.1038/s41574-024-01045-0</ArticleId><ArticleId IdType="pii">10.1038/s41574-024-01045-0</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Thomas, N. J. et al. Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes. Diabetologia 62, 1167–1172 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30969375</ArticleId><ArticleId IdType="pmc">6559997</ArticleId><ArticleId IdType="doi">10.1007/s00125-019-4863-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Hermann, R. et al. Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes – indication of an increased environmental pressure? Diabetologia 46, 420–425 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">12687342</ArticleId><ArticleId IdType="doi">10.1007/s00125-003-1045-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Gillespie, K. M. et al. The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes. Lancet 364, 1699–1700 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15530631</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(04)17357-1</ArticleId></ArticleIdList></Reference><Reference><Citation>Resic-Lindehammer, S. et al. Temporal trends of HLA genotype frequencies of type 1 diabetes patients in Sweden from 1986 to 2005 suggest altered risk. Acta Diabetol. 45, 231–235 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18769865</ArticleId><ArticleId IdType="doi">10.1007/s00592-008-0048-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Fourlanos, S. et al. The rising incidence of type 1 diabetes is accounted for by cases with lower-risk human leukocyte antigen genotypes. Diabetes Care 31, 1546–1549 (2008).</Citation><ArticleIdList><ArticleId IdType="pubmed">18487476</ArticleId><ArticleId IdType="pmc">2494654</ArticleId><ArticleId IdType="doi">10.2337/dc08-0239</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagopian, W. A. et al. TEDDY – The Environmental Determinants of Diabetes in the Young: an observational clinical trial. Ann. N. Y. Acad. Sci. 1079, 320–326 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17130573</ArticleId><ArticleId IdType="doi">10.1196/annals.1375.049</ArticleId></ArticleIdList></Reference><Reference><Citation>TEDDY Study Group The Environmental Determinants of Diabetes in the Young (TEDDY) study. Ann. N. Y. Acad. Sci. 1150, 1–13 (2008).</Citation><ArticleIdList><ArticleId IdType="pmc">2886800</ArticleId><ArticleId IdType="doi">10.1196/annals.1447.062</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris, J. M. Infant and childhood diet and type 1 diabetes risk: recent advances and prospects. Curr. Diab Rep. 10, 345–349 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20640941</ArticleId><ArticleId IdType="pmc">4443269</ArticleId><ArticleId IdType="doi">10.1007/s11892-010-0131-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Elding Larsson, H. et al. Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr. Diabetes 15, 118–126 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24034790</ArticleId><ArticleId IdType="doi">10.1111/pedi.12066</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark, A. et al. Possible heterogeneity of initial pancreatic islet beta-cell autoimmunity heralding type 1 diabetes. J. Intern. Med. 294, 145–158 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37143363</ArticleId><ArticleId IdType="pmc">10524683</ArticleId><ArticleId IdType="doi">10.1111/joim.13648</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewers, M. et al. The Environmental Determinants of Diabetes in the Young (TEDDY) study: 2018 update. Curr. Diab Rep. 18, 136 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30353256</ArticleId><ArticleId IdType="pmc">6415767</ArticleId><ArticleId IdType="doi">10.1007/s11892-018-1113-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Stahl, M. et al. Coeliac disease: what can we learn from prospective studies about disease risk? Lancet Child. Adolesc. Health 8, 63–74 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">37972632</ArticleId><ArticleId IdType="doi">10.1016/S2352-4642(23)00232-8</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn, L. M., Wong, F. S. &amp; Narendran, P. Environmental determinants of type 1 diabetes: from association to proving causality. Front. Immunol. 12, 737964 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34659229</ArticleId><ArticleId IdType="pmc">8518604</ArticleId><ArticleId IdType="doi">10.3389/fimmu.2021.737964</ArticleId></ArticleIdList></Reference><Reference><Citation>Goodwin, G. Type 1 diabetes mellitus and celiac disease: distinct autoimmune disorders that share common pathogenic mechanisms. Horm. Res. Paediatr. 92, 285–292 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31593953</ArticleId><ArticleId IdType="doi">10.1159/000503142</ArticleId></ArticleIdList></Reference><Reference><Citation>TEDDY Study Group The Environmental Determinants of Diabetes in the Young (TEDDY) study: study design. Pediatr. Diabetes 8, 286–298 (2007).</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1399-5448.2007.00269.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio, E. et al. Harmonization of glutamic acid decarboxylase and islet antigen-2 autoantibody assays for National Institute of Diabetes and Digestive and Kidney Diseases consortia. J. Clin. Endocrinol. Metab. 95, 3360–3367 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20444913</ArticleId><ArticleId IdType="pmc">2928900</ArticleId><ArticleId IdType="doi">10.1210/jc.2010-0293</ArticleId></ArticleIdList></Reference><Reference><Citation>Onengut-Gumuscu, S. et al. Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers. Nat. Genet. 47, 381–386 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25751624</ArticleId><ArticleId IdType="pmc">4380767</ArticleId><ArticleId IdType="doi">10.1038/ng.3245</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee, H. S. et al. Biomarker discovery study design for type 1 diabetes in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Metab. Res. Rev. 30, 424–434 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24339168</ArticleId><ArticleId IdType="pmc">4058423</ArticleId><ArticleId IdType="doi">10.1002/dmrr.2510</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagopian, W. A. et al. The Environmental Determinants of Diabetes in the Young (TEDDY): genetic criteria and international diabetes risk screening of 421 000 infants. Pediatr. Diabetes 12, 733–743 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21564455</ArticleId><ArticleId IdType="pmc">3315186</ArticleId><ArticleId IdType="doi">10.1111/j.1399-5448.2011.00774.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Baxter, J. et al. Differences in recruitment and early retention among ethnic minority participants in a large pediatric cohort: the TEDDY study. Contemp. Clin. Trials 33, 633–640 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">22484339</ArticleId><ArticleId IdType="pmc">3686560</ArticleId><ArticleId IdType="doi">10.1016/j.cct.2012.03.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, S. B. et al. The Environmental Determinants of Diabetes in the Young (TEDDY) study: predictors of early study withdrawal among participants with no family history of type 1 diabetes. Pediatr. Diabetes 12, 165–171 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21029290</ArticleId><ArticleId IdType="doi">10.1111/j.1399-5448.2010.00686.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark, B. et al. Enrollment experiences in a pediatric longitudinal observational study: The Environmental Determinants of Diabetes in the Young (TEDDY) study. Contemp. Clin. Trials 32, 517–523 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">21419878</ArticleId><ArticleId IdType="pmc">3118988</ArticleId><ArticleId IdType="doi">10.1016/j.cct.2011.03.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, S. B. et al. Predicting later study withdrawal in participants active in a longitudinal birth cohort study for 1 year: the TEDDY study. J. Pediatr. Psychol. 41, 373–383 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26412232</ArticleId><ArticleId IdType="doi">10.1093/jpepsy/jsv092</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark, B. et al. Participant experiences in The Environmental Determinants of Diabetes in the Young study: common reasons for withdrawing. J. Diabetes Res. 2016, 2720650 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26682228</ArticleId><ArticleId IdType="doi">10.1155/2016/2720650</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark, B. et al. Reasons for staying as a participant in The Environmental Determinants of Diabetes in the Young (TEDDY) longitudinal study. J. Clin. Trials 2, 1000114 (2012).</Citation><ArticleIdList><ArticleId IdType="pubmed">23894727</ArticleId><ArticleId IdType="pmc">3723141</ArticleId><ArticleId IdType="doi">10.4172/2167-0870.1000114</ArticleId></ArticleIdList></Reference><Reference><Citation>Melin, J. et al. Factors assessed in the first year of a longitudinal study predict subsequent study visit compliance: the TEDDY study. Eur. J. Med. Res. 28, 592 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38102669</ArticleId><ArticleId IdType="pmc">10724932</ArticleId><ArticleId IdType="doi">10.1186/s40001-023-01563-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. et al. Factors associated with longitudinal food record compliance in a paediatric cohort study. Public. Health Nutr. 19, 804–813 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26088478</ArticleId><ArticleId IdType="doi">10.1017/S1368980015001883</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth, R. et al. The feasibility of salivary sample collection in an international pediatric cohort: the the TEDDY study. Dev. Psychobiol. 59, 658–667 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28555778</ArticleId><ArticleId IdType="doi">10.1002/dev.21523</ArticleId></ArticleIdList></Reference><Reference><Citation>Driscoll, K. A. et al. Adherence to oral glucose tolerance testing in children in stage 1 of type 1 diabetes: the TEDDY study. Pediatr. Diabetes 22, 360–368 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33179853</ArticleId><ArticleId IdType="pmc">7913602</ArticleId><ArticleId IdType="doi">10.1111/pedi.13149</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik, K. et al. Hierarchical order of distinct autoantibody spreading and progression to type 1 diabetes in the TEDDY study. Diabetes Care 43, 2066–2073 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32641373</ArticleId><ArticleId IdType="pmc">7440899</ArticleId><ArticleId IdType="doi">10.2337/dc19-2547</ArticleId></ArticleIdList></Reference><Reference><Citation>Insel, R. A. et al. Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association. Diabetes Care 38, 1964–1974 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26404926</ArticleId><ArticleId IdType="pmc">5321245</ArticleId><ArticleId IdType="doi">10.2337/dc15-1419</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer, J. P. et al. The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study. Diabetologia 58, 980–987 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25660258</ArticleId><ArticleId IdType="pmc">4393776</ArticleId><ArticleId IdType="doi">10.1007/s00125-015-3514-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio, E. et al. An age-related exponential decline in the risk of multiple islet autoantibody seroconversion during childhood. Diabetes Care 44, 2260–2268 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33627366</ArticleId><ArticleId IdType="pmc">8929192</ArticleId><ArticleId IdType="doi">10.2337/dc20-2122</ArticleId></ArticleIdList></Reference><Reference><Citation>Battaglia, M. et al. Understanding and preventing type 1 diabetes through the unique working model of TrialNet. Diabetologia 60, 2139–2147 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28770323</ArticleId><ArticleId IdType="pmc">5838353</ArticleId><ArticleId IdType="doi">10.1007/s00125-017-4384-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Ilonen, J. et al. Patterns of β-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62, 3636–3640 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23835325</ArticleId><ArticleId IdType="pmc">3781470</ArticleId><ArticleId IdType="doi">10.2337/db13-0300</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkes, M., Cortes, A., van Heel, D. A. &amp; Brown, M. A. Genetic insights into common pathways and complex relationships among immune-mediated diseases. Nat. Rev. Genet. 14, 661–673 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23917628</ArticleId><ArticleId IdType="doi">10.1038/nrg3502</ArticleId></ArticleIdList></Reference><Reference><Citation>Törn, C. et al. Telomere length is not a main factor for the development of islet autoimmunity and type 1 diabetes in the TEDDY study. Sci. Rep. 12, 4516 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35296692</ArticleId><ArticleId IdType="pmc">8927592</ArticleId><ArticleId IdType="doi">10.1038/s41598-022-08058-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Rich, S. S. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 39, 1315–1319 (1990).</Citation><ArticleIdList><ArticleId IdType="pubmed">2227105</ArticleId><ArticleId IdType="doi">10.2337/diab.39.11.1315</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacio, E. et al. Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children. PLoS Med. 15, e1002548 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29614081</ArticleId><ArticleId IdType="pmc">5882115</ArticleId><ArticleId IdType="doi">10.1371/journal.pmed.1002548</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyerlein, A. et al. Progression from islet autoimmunity to clinical type 1 diabetes is influenced by genetic factors: results from the prospective TEDDY study. J. Med. Genet. 56, 602–605 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30287597</ArticleId><ArticleId IdType="doi">10.1136/jmedgenet-2018-105532</ArticleId></ArticleIdList></Reference><Reference><Citation>Singal, D. P. &amp; Blajchman, M. A. Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus. Diabetes 22, 429–432 (1973).</Citation><ArticleIdList><ArticleId IdType="pubmed">4541338</ArticleId><ArticleId IdType="doi">10.2337/diab.22.6.429</ArticleId></ArticleIdList></Reference><Reference><Citation>Nerup, J. et al. HL-A antigens and diabetes mellitus. Lancet 2, 864–866 (1974).</Citation><ArticleIdList><ArticleId IdType="pubmed">4137711</ArticleId><ArticleId IdType="doi">10.1016/S0140-6736(74)91201-X</ArticleId></ArticleIdList></Reference><Reference><Citation>Barbosa, J., Bach, F. H. &amp; Rich, S. S. Genetic heterogeneity of diabetes and HLA. Clin. Genet. 21, 25–32 (1982).</Citation><ArticleIdList><ArticleId IdType="pubmed">6950819</ArticleId><ArticleId IdType="doi">10.1111/j.1399-0004.1982.tb02075.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Todd, J. A., Bell, J. I. &amp; McDevitt, H. O. HLA-DQβ gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329, 599–604 (1987).</Citation><ArticleIdList><ArticleId IdType="pubmed">3309680</ArticleId><ArticleId IdType="doi">10.1038/329599a0</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu, X. et al. Additive and interaction effects at three amino acid positions in HLA-DQ and HLA-DR molecules drive type 1 diabetes risk. Nat. Genet. 47, 898–905 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26168013</ArticleId><ArticleId IdType="pmc">4930791</ArticleId><ArticleId IdType="doi">10.1038/ng.3353</ArticleId></ArticleIdList></Reference><Reference><Citation>Bell, G. I., Horita, S. &amp; Karam, J. H. A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus. Diabetes 33, 176–183 (1984).</Citation><ArticleIdList><ArticleId IdType="pubmed">6363172</ArticleId><ArticleId IdType="doi">10.2337/diab.33.2.176</ArticleId></ArticleIdList></Reference><Reference><Citation>Nistico, L. et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum. Mol. Genet. 5, 1075–1080 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8817351</ArticleId><ArticleId IdType="doi">10.1093/hmg/5.7.1075</ArticleId></ArticleIdList></Reference><Reference><Citation>Bottini, N. et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet. 36, 337–338 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15004560</ArticleId><ArticleId IdType="doi">10.1038/ng1323</ArticleId></ArticleIdList></Reference><Reference><Citation>Vella, A. et al. Localization of a type 1 diabetes locus in the IL2RA/CD25 region by use of tag single-nucleotide polymorphisms. Am. J. Hum. Genet. 76, 773–779 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">15776395</ArticleId><ArticleId IdType="pmc">1199367</ArticleId><ArticleId IdType="doi">10.1086/429843</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42, 200–207 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30655379</ArticleId><ArticleId IdType="pmc">6341291</ArticleId><ArticleId IdType="doi">10.2337/dc18-1785</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferrat, L. A. et al. A combined risk score enhances prediction of type 1 diabetes among susceptible children. Nat. Med. 26, 1247–1255 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32770166</ArticleId><ArticleId IdType="pmc">7556983</ArticleId><ArticleId IdType="doi">10.1038/s41591-020-0930-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Redondo, M. J. et al. Type 1 diabetes in diverse ancestries and the use of genetic risk scores. Lancet Diabetes Endocrinol. 10, 597–608 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35724677</ArticleId><ArticleId IdType="pmc">10024251</ArticleId><ArticleId IdType="doi">10.1016/S2213-8587(22)00159-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik, K. et al. Prospective virome analyses in young children at increased genetic risk for type 1 diabetes. Nat. Med. 25, 1865–1872 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31792456</ArticleId><ArticleId IdType="pmc">6898786</ArticleId><ArticleId IdType="doi">10.1038/s41591-019-0667-0</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer, J. P. et al. Predictors of the initiation of islet autoimmunity and progression to multiple autoantibodies and clinical diabetes: the TEDDY study. Diabetes Care 45, 2271–2281 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36150053</ArticleId><ArticleId IdType="pmc">9643148</ArticleId><ArticleId IdType="doi">10.2337/dc21-2612</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris, J. M. et al. Plasma 25-hydroxyvitamin D concentration and risk of islet autoimmunity. Diabetes 67, 146–154 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29061729</ArticleId><ArticleId IdType="doi">10.2337/db17-0802</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir, O. et al. Genetic variation within the HLA-DRA1 gene modulates susceptibility to type 1 diabetes in HLA-DR3 homozygotes. Diabetes 68, 1523–1527 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30962219</ArticleId><ArticleId IdType="pmc">6609989</ArticleId><ArticleId IdType="doi">10.2337/db18-1128</ArticleId></ArticleIdList></Reference><Reference><Citation>Andersson Svärd, A. et al. Possible relationship between the HLA-DRA1 intron haplotype of three single-nucleotide polymorphisms in intron 1 of the HLA-DRA1 gene and autoantibodies in children at increased genetic risk for autoimmune type 1 diabetes. Immunohorizons 6, 614–629 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35981747</ArticleId><ArticleId IdType="doi">10.4049/immunohorizons.2200039</ArticleId></ArticleIdList></Reference><Reference><Citation>Aydemir, O. et al. Polymorphisms in Intron 1 of HLA-DRA differentially associate with type 1 diabetes and celiac disease and implicate involvement of complement system genes C4A and C4B. eLife 12, RP89068 (2023).</Citation></Reference><Reference><Citation>Lin, J. et al. Distinct transcriptomic profiles in children prior to the appearance of type 1 diabetes-linked islet autoantibodies and following enterovirus infection. Nat. Commun. 14, 7630 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37993433</ArticleId><ArticleId IdType="pmc">10665402</ArticleId><ArticleId IdType="doi">10.1038/s41467-023-42763-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Braenne, I. et al. Dynamic changes in immune gene co-expression networks predict development of type 1 diabetes. Sci. Rep. 11, 22651 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34811390</ArticleId><ArticleId IdType="pmc">8609030</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-01840-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Xhonneux, L. P. et al. Transcriptional networks in at-risk individuals identify signatures of type 1 diabetes progression. Sci. Transl. Med. 13, eabd5666 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33790023</ArticleId><ArticleId IdType="pmc">8447843</ArticleId><ArticleId IdType="doi">10.1126/scitranslmed.abd5666</ArticleId></ArticleIdList></Reference><Reference><Citation>Vatanen, T. et al. The human gut microbiome in early-onset type 1 diabetes from the TEDDY study. Nature 562, 589–594 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30356183</ArticleId><ArticleId IdType="pmc">6296767</ArticleId><ArticleId IdType="doi">10.1038/s41586-018-0620-2</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart, C. J. et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature 562, 583–588 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30356187</ArticleId><ArticleId IdType="pmc">6415775</ArticleId><ArticleId IdType="doi">10.1038/s41586-018-0617-x</ArticleId></ArticleIdList></Reference><Reference><Citation>Sioofy-Khojine, A. B. et al. Coxsackievirus B1 infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes. Diabetologia 61, 1193–1202 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29404673</ArticleId><ArticleId IdType="doi">10.1007/s00125-018-4561-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Cinek, O. et al. Enterovirus RNA in longitudinal blood samples and risk of islet autoimmunity in children with a high genetic risk of type 1 diabetes: the MIDIA study. Diabetologia 57, 2193–2200 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">25047648</ArticleId><ArticleId IdType="doi">10.1007/s00125-014-3327-4</ArticleId></ArticleIdList></Reference><Reference><Citation>Dunne, J. L. et al. Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes. Diabetologia 62, 744–753 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30675626</ArticleId><ArticleId IdType="pmc">6450860</ArticleId><ArticleId IdType="doi">10.1007/s00125-019-4811-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnrot, M. et al. Respiratory infections are temporally associated with initiation of type 1 diabetes autoimmunity: the TEDDY study. Diabetologia 60, 1931–1940 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28770319</ArticleId><ArticleId IdType="pmc">5697762</ArticleId><ArticleId IdType="doi">10.1007/s00125-017-4365-5</ArticleId></ArticleIdList></Reference><Reference><Citation>Hyoty, H. et al. A prospective study of the role of coxsackie B and other enterovirus infections in the pathogenesis of IDDM. Childhood Diabetes in Finland (DiMe) Study Group. Diabetes 44, 652–657 (1995).</Citation><ArticleIdList><ArticleId IdType="pubmed">7789630</ArticleId><ArticleId IdType="doi">10.2337/diab.44.6.652</ArticleId></ArticleIdList></Reference><Reference><Citation>Lonnrot, M. et al. Gastrointestinal infections modulate the risk for insulin autoantibodies as the first-appearing autoantibody in the TEDDY study. Diabetes Care 46, 1908–1915 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37607456</ArticleId><ArticleId IdType="doi">10.2337/dc23-0518</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppainen, K. M. et al. Association between early-life antibiotic use and the risk of islet or celiac disease autoimmunity. JAMA Pediatr. 171, 1217–1225 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29052687</ArticleId><ArticleId IdType="pmc">5716863</ArticleId><ArticleId IdType="doi">10.1001/jamapediatrics.2017.2905</ArticleId></ArticleIdList></Reference><Reference><Citation>Duong, Q. A., Pittet, L. F., Curtis, N. &amp; Zimmermann, P. Antibiotic exposure and adverse long-term health outcomes in children: a systematic review and meta-analysis. J. Infect. 85, 213–300 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35021114</ArticleId><ArticleId IdType="doi">10.1016/j.jinf.2022.01.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Elding Larsson, H. et al. Pandemrix® vaccination is not associated with increased risk of islet autoimmunity or type 1 diabetes in the TEDDY study children. Diabetologia 61, 193–202 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28990147</ArticleId><ArticleId IdType="doi">10.1007/s00125-017-4448-3</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrén Aronsson, C. et al. Association of gluten intake during the first 5 years of life with incidence of celiac disease autoimmunity and celiac disease among children at increased risk. JAMA 322, 514–523 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31408136</ArticleId><ArticleId IdType="pmc">6692672</ArticleId><ArticleId IdType="doi">10.1001/jama.2019.10329</ArticleId></ArticleIdList></Reference><Reference><Citation>Hagopian, W. et al. Co-occurrence of type 1 diabetes and celiac disease autoimmunity. Pediatrics 140, e20171305 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29018046</ArticleId><ArticleId IdType="doi">10.1542/peds.2017-1305</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, E. et al. Risk of pediatric celiac disease according to HLA haplotype and country. N. Engl. J. Med. 371, 42–49 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24988556</ArticleId><ArticleId IdType="pmc">4163840</ArticleId><ArticleId IdType="doi">10.1056/NEJMoa1313977</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma, A. et al. Identification of non-HLA genes associated with celiac disease and country-specific differences in a large, international pediatric cohort. PLoS ONE 11, e0152476 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">27015091</ArticleId><ArticleId IdType="pmc">4807782</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0152476</ArticleId></ArticleIdList></Reference><Reference><Citation>Hadley, D. et al. HLA-DPB1*04:01 protects genetically susceptible children from celiac disease autoimmunity in the TEDDY study. Am. J. Gastroenterol. 110, 915–920 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26010309</ArticleId><ArticleId IdType="pmc">4487515</ArticleId><ArticleId IdType="doi">10.1038/ajg.2015.150</ArticleId></ArticleIdList></Reference><Reference><Citation>Koletzko, S. et al. Caesarean section on the risk of celiac disease in the offspring: the teddy study. J. Pediatr. Gastroenterol. Nutr. 66, 417–424 (2017).</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MPG.0000000000001682</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang, J. et al. Maternal use of dietary supplements during pregnancy is not associated with coeliac disease in the offspring: the environmental determinants of diabetes in the young (TEDDY) study. Br. J. Nutr. 117, 466–472 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28249640</ArticleId><ArticleId IdType="pmc">5477643</ArticleId><ArticleId IdType="doi">10.1017/S0007114517000332</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. Gluten consumption during late pregnancy and risk of celiac disease in the offspring: the TEDDY birth cohort. Am. J. Clin. Nutr. 102, 1216–1221 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">26447157</ArticleId><ArticleId IdType="pmc">4625598</ArticleId><ArticleId IdType="doi">10.3945/ajcn.115.119370</ArticleId></ArticleIdList></Reference><Reference><Citation>Andren Aronsson, C. et al. 25(OH)D levels in infancy is associated with celiac disease autoimmunity in at-risk children: a case-control study. Front. Nutr. 8, 720041 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">34604278</ArticleId><ArticleId IdType="pmc">8479793</ArticleId><ArticleId IdType="doi">10.3389/fnut.2021.720041</ArticleId></ArticleIdList></Reference><Reference><Citation>Aronsson, C. A. et al. Age at gluten introduction and risk of celiac disease. Pediatrics 135, 239–245 (2015).</Citation><ArticleIdList><ArticleId IdType="pubmed">25601977</ArticleId><ArticleId IdType="pmc">4306795</ArticleId><ArticleId IdType="doi">10.1542/peds.2014-1787</ArticleId></ArticleIdList></Reference><Reference><Citation>Andren Aronsson, C. et al. Effects of gluten intake on risk of celiac disease: a case-control study on a Swedish birth cohort. Clin. Gastroenterol. Hepatol. 14, 403–409.e3 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26453955</ArticleId><ArticleId IdType="doi">10.1016/j.cgh.2015.09.030</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. Early probiotic supplementation and the risk of celiac disease in children at genetic risk. Nutrients 11, 1790 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31382440</ArticleId><ArticleId IdType="pmc">6722940</ArticleId><ArticleId IdType="doi">10.3390/nu11081790</ArticleId></ArticleIdList></Reference><Reference><Citation>Kemppainen, K. M. et al. Factors that increase risk of celiac disease autoimmunity after a gastrointestinal infection in early life. Clin. Gastroenterol. Hepatol. 15, 694–702.e5 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">27840181</ArticleId><ArticleId IdType="doi">10.1016/j.cgh.2016.10.033</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindfors, K. et al. Metagenomics of the faecal virome indicate a cumulative effect of enterovirus and gluten amount on the risk of coeliac disease autoimmunity in genetically at risk children: the TEDDY study. Gut 69, 1416–1422 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31744911</ArticleId><ArticleId IdType="doi">10.1136/gutjnl-2019-319809</ArticleId></ArticleIdList></Reference><Reference><Citation>Kulkarni, A., Muralidharan, C., May, S. C., Tersey, S. A. &amp; Mirmira, R. G. Inside the β cell: molecular stress response pathways in diabetes pathogenesis. Endocrinology 164, bqac184 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36317483</ArticleId><ArticleId IdType="pmc">9667558</ArticleId><ArticleId IdType="doi">10.1210/endocr/bqac184</ArticleId></ArticleIdList></Reference><Reference><Citation>Bekris, L. M. et al. Glutamate cysteine ligase catalytic subunit promoter polymorphisms and associations with type 1 diabetes age-at-onset and GAD65 autoantibody levels. Exp. Clin. Endocrinol. Diabetes 115, 221–228 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17479437</ArticleId><ArticleId IdType="doi">10.1055/s-2007-970574</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilkin, T. J. The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes. Diabetologia 44, 914–922 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">11508279</ArticleId><ArticleId IdType="doi">10.1007/s001250100548</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. Distinct growth phases in early life associated with the risk of type 1 diabetes: the TEDDY study. Diabetes Care 43, 556–562 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31896601</ArticleId><ArticleId IdType="pmc">7035588</ArticleId><ArticleId IdType="doi">10.2337/dc19-1670</ArticleId></ArticleIdList></Reference><Reference><Citation>Elding Larsson, H. et al. Growth and risk for islet autoimmunity and progression to type 1 diabetes in early childhood: The Environmental Determinants of Diabetes in the Young study. Diabetes 65, 1988–1995 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26993064</ArticleId><ArticleId IdType="pmc">4915577</ArticleId><ArticleId IdType="doi">10.2337/db15-1180</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrén Aronsson, C. et al. Dietary intake and body mass index influence the risk of islet autoimmunity in genetically at-risk children: a mediation analysis using the TEDDY cohort. Pediatr. Diabetes 2023, 3945064 (2023).</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2023/3945064</ArticleId></ArticleIdList></Reference><Reference><Citation>Warncke, K. et al. The influence of pubertal development on autoantibody appearance and progression to type 1 diabetes in the TEDDY study. J. Endocr. Soc. 8, bvae103 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38867880</ArticleId><ArticleId IdType="pmc">11167566</ArticleId><ArticleId IdType="doi">10.1210/jendso/bvae103</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. Food composition database harmonization for between-country comparisons of nutrient data in the TEDDY study. J. Food Compost. Anal. 24, 494–505 (2011).</Citation><ArticleIdList><ArticleId IdType="pubmed">22058606</ArticleId><ArticleId IdType="pmc">3205351</ArticleId><ArticleId IdType="doi">10.1016/j.jfca.2011.01.012</ArticleId></ArticleIdList></Reference><Reference><Citation>Joslowski, G. et al. Development of a harmonized food grouping system for between-country comparisons in the TEDDY study. J. Food Compost. Anal. 63, 79–88 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">29151672</ArticleId><ArticleId IdType="pmc">5690566</ArticleId><ArticleId IdType="doi">10.1016/j.jfca.2017.07.037</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel, S. et al. First infant formula type and risk of islet autoimmunity in The Environmental Determinants of Diabetes in the Young (TEDDY) study. Diabetes Care 40, 398–404 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28096222</ArticleId><ArticleId IdType="pmc">5319477</ArticleId><ArticleId IdType="doi">10.2337/dc16-1624</ArticleId></ArticleIdList></Reference><Reference><Citation>Knip, M. et al. Hydrolyzed infant formula and early β-cell autoimmunity: a randomized clinical trial. JAMA 311, 2279–2287 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24915259</ArticleId><ArticleId IdType="pmc">4225544</ArticleId><ArticleId IdType="doi">10.1001/jama.2014.5610</ArticleId></ArticleIdList></Reference><Reference><Citation>Writing Group for the TRIGR Study Group Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial. JAMA 319, 38–48 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">5833549</ArticleId><ArticleId IdType="doi">10.1001/jama.2017.19826</ArticleId></ArticleIdList></Reference><Reference><Citation>Hummel, M., Bonifacio, E., Naserke, H. E. &amp; Ziegler, A. G. Elimination of dietary gluten does not reduce titers of type 1 diabetes-associated autoantibodies in high-risk subjects. Diabetes Care 25, 1111–1116 (2002).</Citation><ArticleIdList><ArticleId IdType="pubmed">12087006</ArticleId><ArticleId IdType="doi">10.2337/diacare.25.7.1111</ArticleId></ArticleIdList></Reference><Reference><Citation>Fuchtenbusch, M., Ziegler, A. G. &amp; Hummel, M. Elimination of dietary gluten and development of type 1 diabetes in high risk subjects. Rev. Diabet. Stud. 1, 39–41 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">17491663</ArticleId><ArticleId IdType="pmc">1783529</ArticleId><ArticleId IdType="doi">10.1900/RDS.2004.1.39</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. Early infant diet and islet autoimmunity in the TEDDY study. Diabetes Care 41, 522–530 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29343517</ArticleId><ArticleId IdType="pmc">5829968</ArticleId><ArticleId IdType="doi">10.2337/dc17-1983</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. Association of early exposure of probiotics and islet autoimmunity in the TEDDY study. JAMA Pediatr. 170, 20–28 (2016).</Citation><ArticleIdList><ArticleId IdType="pubmed">26552054</ArticleId><ArticleId IdType="pmc">4803028</ArticleId><ArticleId IdType="doi">10.1001/jamapediatrics.2015.2757</ArticleId></ArticleIdList></Reference><Reference><Citation>Uusitalo, U. et al. HLA genotype and probiotics modify the association between timing of solid food introduction and islet autoimmunity in the TEDDY study. Diabetes Care 46, 1839–1847 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37579501</ArticleId><ArticleId IdType="pmc">10516243</ArticleId><ArticleId IdType="doi">10.2337/dc23-0417</ArticleId></ArticleIdList></Reference><Reference><Citation>Hakola, L. et al. Intake of B vitamins and the risk of developing islet autoimmunity and type 1 diabetes in the TEDDY study. Eur. J. Nutr. 63, 1329–1338 (2024).</Citation><ArticleIdList><ArticleId IdType="pubmed">38413484</ArticleId><ArticleId IdType="pmc">11139689</ArticleId><ArticleId IdType="doi">10.1007/s00394-024-03346-6</ArticleId></ArticleIdList></Reference><Reference><Citation>Thorsen, S. U. et al. Interaction between dietary iron intake and genetically determined iron overload: risk of islet autoimmunity and progression to type 1 diabetes in the TEDDY study. Diabetes Care 46, 1014–1018 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">36867433</ArticleId><ArticleId IdType="pmc">10154662</ArticleId><ArticleId IdType="doi">10.2337/dc22-1359</ArticleId></ArticleIdList></Reference><Reference><Citation>Niinistö, S. et al. Children’s erythrocyte fatty acids are associated with the risk of islet autoimmunity. Sci. Rep. 11, 3627 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33574451</ArticleId><ArticleId IdType="pmc">7878879</ArticleId><ArticleId IdType="doi">10.1038/s41598-021-82200-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris, J. M. et al. Omega-3 polyunsaturated fatty acid intake and islet autoimmunity in children at increased risk for type 1 diabetes. JAMA 298, 1420–1428 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17895458</ArticleId><ArticleId IdType="doi">10.1001/jama.298.12.1420</ArticleId></ArticleIdList></Reference><Reference><Citation>Norris, J. M. et al. Erythrocyte membrane docosapentaenoic acid levels are associated with islet autoimmunity: the Diabetes Autoimmunity Study in the Young. Diabetologia 57, 295–304 (2014).</Citation><ArticleIdList><ArticleId IdType="pubmed">24240437</ArticleId><ArticleId IdType="doi">10.1007/s00125-013-3106-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Niinisto, S. et al. Fatty acid status in infancy is associated with the risk of type 1 diabetes-associated autoimmunity. Diabetologia 60, 1223–1233 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28474159</ArticleId><ArticleId IdType="doi">10.1007/s00125-017-4280-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattila, M. et al. Plasma ascorbic acid and the risk of islet autoimmunity and type 1 diabetes: the TEDDY study. Diabetologia 63, 278–286 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">31728565</ArticleId><ArticleId IdType="doi">10.1007/s00125-019-05028-z</ArticleId></ArticleIdList></Reference><Reference><Citation>Li, Q. et al. Longitudinal metabolome-wide signals prior to the appearance of a first islet autoantibody in children participating in the TEDDY study. Diabetes 69, 465–476 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32029481</ArticleId><ArticleId IdType="pmc">7034190</ArticleId><ArticleId IdType="doi">10.2337/db19-0756</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepa, A. &amp; Ludvigsson, J. Psychological stress and the risk of diabetes-related autoimmunity: a review article. Neuroimmunomodulation 13, 301–308 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17709952</ArticleId><ArticleId IdType="doi">10.1159/000104858</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharif, K. et al. Psychological stress and type 1 diabetes mellitus: what is the link? Expert. Rev. Clin. Immunol. 14, 1081–1088 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">30336709</ArticleId><ArticleId IdType="doi">10.1080/1744666X.2018.1538787</ArticleId></ArticleIdList></Reference><Reference><Citation>Sepa, A., Frodi, A. &amp; Ludvigsson, J. Mothers’ experiences of serious life events increase the risk of diabetes-related autoimmunity in their children. Diabetes Care 28, 2394–2399 (2005).</Citation><ArticleIdList><ArticleId IdType="pubmed">16186269</ArticleId><ArticleId IdType="doi">10.2337/diacare.28.10.2394</ArticleId></ArticleIdList></Reference><Reference><Citation>Lundgren, M., Ellström, K. &amp; Elding Larsson, H. Influence of early-life parental severe life events on the risk of type 1 diabetes in children: the DiPiS study. Acta Diabetol. 55, 797–804 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">29752553</ArticleId><ArticleId IdType="pmc">6060880</ArticleId><ArticleId IdType="doi">10.1007/s00592-018-1150-y</ArticleId></ArticleIdList></Reference><Reference><Citation>Roth, R. et al. The association between stressful life events and respiratory infections during the first 4 years of life: The Environmental Determinants of Diabetes in the Young study. Stress. Health 35, 289–303 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30768831</ArticleId><ArticleId IdType="pmc">6697245</ArticleId><ArticleId IdType="doi">10.1002/smi.2861</ArticleId></ArticleIdList></Reference><Reference><Citation>Virk, J. et al. Early life disease programming during the preconception and prenatal period: making the link between stressful life events and type-1 diabetes. PLoS ONE 5, e11523 (2010).</Citation><ArticleIdList><ArticleId IdType="pubmed">20634978</ArticleId><ArticleId IdType="pmc">2901388</ArticleId><ArticleId IdType="doi">10.1371/journal.pone.0011523</ArticleId></ArticleIdList></Reference><Reference><Citation>Lynch, K. F. et al. Gestational respiratory infections interacting with offspring HLA and CTLA-4 modifies incident β-cell autoantibodies. J. Autoimmun. 86, 93–103 (2018).</Citation><ArticleIdList><ArticleId IdType="pubmed">28941965</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2017.09.005</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson, S. B. et al. First-appearing islet autoantibodies for type 1 diabetes in young children: maternal life events during pregnancy and the child’s genetic risk. Diabetologia 64, 591–602 (2021).</Citation><ArticleIdList><ArticleId IdType="pubmed">33404683</ArticleId><ArticleId IdType="pmc">7880544</ArticleId><ArticleId IdType="doi">10.1007/s00125-020-05344-9</ArticleId></ArticleIdList></Reference><Reference><Citation>Roll, U. et al. Perinatal autoimmunity in offspring of diabetic parents. the German multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood. Diabetes 45, 967–973 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8666150</ArticleId><ArticleId IdType="doi">10.2337/diab.45.7.967</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler, A. G., Hummel, M., Schenker, M. &amp; Bonifacio, E. Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes: the 2-year analysis of the German BABYDIAB study. Diabetes 48, 460–468 (1999).</Citation><ArticleIdList><ArticleId IdType="pubmed">10078544</ArticleId><ArticleId IdType="doi">10.2337/diabetes.48.3.460</ArticleId></ArticleIdList></Reference><Reference><Citation>Hahl, J., Simell, T., Ilonen, J., Knip, M. &amp; Simell, O. Costs of predicting IDDM. Diabetologia 41, 79–85 (1998).</Citation><ArticleIdList><ArticleId IdType="pubmed">9498634</ArticleId><ArticleId IdType="doi">10.1007/s001250050870</ArticleId></ArticleIdList></Reference><Reference><Citation>Rewers, M. et al. Newborn screening for HLA markers associated with IDDM: Diabetes Autoimmunity Study in the Young (DAISY). Diabetologia 39, 807–812 (1996).</Citation><ArticleIdList><ArticleId IdType="pubmed">8817105</ArticleId><ArticleId IdType="doi">10.1007/s001250050514</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett Johnson, S., Baughcum, A. E., Carmichael, S. K., She, J. X. &amp; Schatz, D. A. Maternal anxiety associated with newborn genetic screening for type 1 diabetes. Diabetes Care 27, 392–397 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">14747219</ArticleId><ArticleId IdType="doi">10.2337/diacare.27.2.392</ArticleId></ArticleIdList></Reference><Reference><Citation>Wion, E. et al. Population-wide infant screening for HLA-based type 1 diabetes risk via dried blood spots from the public health infrastructure. Ann. N. Y. Acad. Sci. 1005, 400–403 (2003).</Citation><ArticleIdList><ArticleId IdType="pubmed">14679100</ArticleId><ArticleId IdType="doi">10.1196/annals.1288.067</ArticleId></ArticleIdList></Reference><Reference><Citation>Larsson, K. et al. Genetic and perinatal factors as risk for childhood type 1 diabetes. Diabetes Metab. Res. Rev. 20, 429–437 (2004).</Citation><ArticleIdList><ArticleId IdType="pubmed">15386804</ArticleId><ArticleId IdType="doi">10.1002/dmrr.506</ArticleId></ArticleIdList></Reference><Reference><Citation>Stene, L. C. et al. Islet autoantibody development during follow-up of high-risk children from the general Norwegian population from three months of age: design and early results from the MIDIA study. J. Autoimmun. 29, 44–51 (2007).</Citation><ArticleIdList><ArticleId IdType="pubmed">17560077</ArticleId><ArticleId IdType="doi">10.1016/j.jaut.2007.04.003</ArticleId></ArticleIdList></Reference><Reference><Citation>Ludvigsson, J., Ludvigsson, M. &amp; Sepa, A. Screening for prediabetes in the general child population: maternal attitude to participation. Pediatr. Diabetes 2, 170–174 (2001).</Citation><ArticleIdList><ArticleId IdType="pubmed">15016182</ArticleId><ArticleId IdType="doi">10.1034/j.1399-5448.2001.20405.x</ArticleId></ArticleIdList></Reference><Reference><Citation>Lernmark, B., Lynch, K. &amp; Lernmark, A. Cord blood islet autoantibodies are related to stress in the mother during pregnancy. Ann. N. Y. Acad. Sci. 1079, 345–349 (2006).</Citation><ArticleIdList><ArticleId IdType="pubmed">17130577</ArticleId><ArticleId IdType="doi">10.1196/annals.1375.053</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik, K. et al. Methods, quality control and specimen management in an international multicentre investigation of type 1 diabetes: TEDDY. Diabetes Metab. Res. Rev. 29, 557–567 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23674484</ArticleId><ArticleId IdType="pmc">3992860</ArticleId><ArticleId IdType="doi">10.1002/dmrr.2427</ArticleId></ArticleIdList></Reference><Reference><Citation>Williams, A. J., Bingley, P. J., Bonifacio, E., Palmer, J. P. &amp; Gale, E. A. A novel micro-assay for insulin autoantibodies. J. Autoimmun. 10, 473–478 (1997).</Citation><ArticleIdList><ArticleId IdType="pubmed">9376075</ArticleId><ArticleId IdType="doi">10.1006/jaut.1997.0154</ArticleId></ArticleIdList></Reference><Reference><Citation>Krischer, J. P. et al. Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study. Diabetes Care 40, 1194–1202 (2017).</Citation><ArticleIdList><ArticleId IdType="pubmed">28646072</ArticleId><ArticleId IdType="pmc">5566280</ArticleId><ArticleId IdType="doi">10.2337/dc17-0238</ArticleId></ArticleIdList></Reference><Reference><Citation>Endesfelder, D. et al. Time-resolved autoantibody profiling facilitates stratification of preclinical type 1 diabetes in children. Diabetes 68, 119–130 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">30305370</ArticleId><ArticleId IdType="doi">10.2337/db18-0594</ArticleId></ArticleIdList></Reference><Reference><Citation>Jacobsen, L. M. et al. Heterogeneity of DKA incidence and age-specific clinical characteristics in children diagnosed with type 1 diabetes in the TEDDY study. Diabetes Care 45, 624–633 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">35043162</ArticleId><ArticleId IdType="pmc">8918232</ArticleId><ArticleId IdType="doi">10.2337/dc21-0422</ArticleId></ArticleIdList></Reference><Reference><Citation>Vehik, K. et al. Rising hemoglobin A1c in the nondiabetic range predicts progression of type 1 diabetes as well as oral glucose tolerance tests. Diabetes Care 45, 2342–2349 (2022).</Citation><ArticleIdList><ArticleId IdType="pubmed">36150054</ArticleId><ArticleId IdType="pmc">9587339</ArticleId><ArticleId IdType="doi">10.2337/dc22-0828</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu, X. et al. Physical activity and the development of islet autoimmunity and type 1 diabetes in 5- to 15-year-old children followed in the TEDDY study. Diabetes Care 46, 1409–1416 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37141102</ArticleId><ArticleId IdType="pmc">10300517</ArticleId><ArticleId IdType="doi">10.2337/dc23-0036</ArticleId></ArticleIdList></Reference><Reference><Citation>Hård Af Segerstad, E. M. et al. Associations of dietary patterns between age 9 and 24 months with risk of celiac disease autoimmunity and celiac disease among children at increased risk. Am. J. Clin. Nutr. 118, 1099–1105 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">38044022</ArticleId><ArticleId IdType="pmc">10925856</ArticleId><ArticleId IdType="doi">10.1016/j.ajcnut.2023.08.009</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu, E. S. et al. Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity. Cell Rep. Med. 4, 101093 (2023).</Citation><ArticleIdList><ArticleId IdType="pubmed">37390828</ArticleId><ArticleId IdType="pmc">10394168</ArticleId><ArticleId IdType="doi">10.1016/j.xcrm.2023.101093</ArticleId></ArticleIdList></Reference><Reference><Citation>Penno, M. A. et al. Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes. BMC Pediatr. 13, 124 (2013).</Citation><ArticleIdList><ArticleId IdType="pubmed">23941366</ArticleId><ArticleId IdType="pmc">3751791</ArticleId><ArticleId IdType="doi">10.1186/1471-2431-13-124</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>